Oragenics, Inc. is a development-stage company that is focused on fighting infectious diseases, including those caused by coronaviruses and multidrug-resistant organisms. The Company’s lead product NT-CoV2-1 is an intranasal vaccine candidate to prev... Read more
SeekingAlpha
SeekingAlpha
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.